<DOC>
	<DOCNO>NCT02866981</DOCNO>
	<brief_summary>The purpose registry determine select patient CNS metastatic disease safely observe rather treat . The investigator hypothesize subset patient small asymptomatic CNS mets require treatment , patient simply observe CNS progression .</brief_summary>
	<brief_title>Observation Patients With Asymptomatic CNS Metastatic Disease</brief_title>
	<detailed_description>Subjects give consultation physician investigator department one study investigator , introduce study subject potentially eligible . Information collect initial assessment : - Quality life survey ( FACT-Br ) - History Physical exam ( include KPS , disease status recent non-CNS imaging , chemotherapy history , age ) . - Measurement walk pace : patient walk pre- measure 6 meter , patient instruct walk normal pace . The time require travel distance record . For patient wheelchair bound otherwise immobile , pace record ` 0 ` . - Neurocognitive testing ( Montreal Cognitive Assessment ) - MRI scan contrast ( must within 6 week ) Observation Follow-up Visits : - Patients see 6 week every 2 month follow-up ( physical exam ) repeat MRI contrast time - FACT-Br survey fill follow-up - Neurocognitive status ( Montreal Cognitive Assessment ) Treatment Progression : - Progression define : Increase size &gt; 1 cm ( &gt; 2.0 patient treat targeted therapy ) ; Interval growth 0.4 cm 6-8 week ; Development edema increase edema ; Development symptom CNS lesion ; Patient preference - Patients meet criterion treatment treat discretion treat physician ; option include whole brain radiation , radiosurgery , surgery . The study provide financial compensation subject</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>CNS metastatic disease meet follow : No lesion great 0.8 cm patient target therapy CNS penetration No lesion great 1.5 cm patient target therapy CNS penetration . No previous treatment observe lesion . Patients may lesion treat long least one index lesion treat . For example , patient may 3 lesion treat March 2012 radiosurgery recent scan find new 0.5 cm lesion , patient eligible . Less 5 untreated CNS lesion . Able MRI scan contrast All CNS lesion asymptomatic . Patient may symptoms previous treatment cancer outside CNS symptom attributable current CNS metastatic disease . This left discretion treat physician instance easy sometimes CNS metastatic disease incidental finding unrelated symptom . Eligible primary Lung ( NSCLC ) Lung ( SCLC ) previous Whole brain radiation GI Head Neck Gyn Prostate Breast Kidney Melanoma Sarcoma CNS lesion meet follow : No lesion great 0.8 cm patient target therapy CNS penetration No lesion great 1.5 cm patient target therapy CNS penetration . More 5 CNS lesion ( previously treat lesion either surgery radiation , time protocol SRS must 5 less untreated lesion ) . Symptomatic CNS lesion Ineligible primary Lymphoma Primary CNS tumor SCLC previous whole brain radiation Leptomeningeal disease CNS Patients unable MRI ( secondary example metal hardware ) Patients unable MRI contrast ( secondary example poor renal function CNS lesion &gt; 0.8 cm dimension patient target therapy CNS penetration &gt; 1.5 cm patient target therapy CNS penetration . Note KPS cutoff eligibility</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Brain Metastases</keyword>
</DOC>